Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/107082
Title: | ECM-enriched alginate hydrogels for bioartificial pancreas: an ideal niche to improve insulin secretion and diabetic glucose profile | Authors: | Crisóstomo, Joana Pereira, Ana M. Bidarra, Sílvia J. Gonçalves, Ana C. Granja, Pedro L. Coelho, Jorge Fj Barrias, Cristina C Seiça, Raquel |
Keywords: | Diabetes; bioartificial pancreas; alginate hydrogels; extracellular matrix; beta cells | Issue Date: | 2019 | Publisher: | SAGE | Serial title, monograph or event: | Journal of Applied Biomaterials and Functional Materials | Volume: | 17 | Issue: | 4 | Abstract: | Introduction: The success of a bioartificial pancreas crucially depends on ameliorating encapsulated beta cells survival and function. By mimicking the cellular in vivo niche, the aim of this study was to develop a novel model for beta cells encapsulation capable of establishing an appropriate microenvironment that supports interactions between cells and extracellular matrix (ECM) components. Methods: ECM components (Arg-Gly-Asp, abbreviated as RGD) were chemically incorporated in alginate hydrogels (alginate-RGD). After encapsulation, INS-1E beta cells outcome was analyzed in vitro and after their implantation in an animal model of diabetes. Results: Our alginate-RGD model demonstrated to be a good in vitro niche for supporting beta cells viability, proliferation, and activity, namely by improving the key feature of insulin secretion. RGD peptides promoted cell–matrix interactions, enhanced endogenous ECM components expression, and favored the assembly of individual cells into multicellular spheroids, an essential configuration for proper beta cell functioning. In vivo, our pivotal model for diabetes treatment exhibited an improved glycemic profile of type 2 diabetic rats, where insulin secreted from encapsulated cells was more efficiently used. Conclusions: We were able to successfully introduce a novel valuable function in an old ally in biomedical applications, the alginate. The proposed alginate-RGD model stands out as a promising approach to improve beta cells survival and function, increasing the success of this therapeutic strategy, which might greatly improve the quality of life of an increasing number of diabetic patients worldwide. | URI: | https://hdl.handle.net/10316/107082 | ISSN: | 2280-8000 2280-8000 |
DOI: | 10.1177/2280800019848923 | Rights: | openAccess |
Appears in Collections: | I&D IBILI - Artigos em Revistas Internacionais |
Files in This Item:
SCOPUSTM
Citations
13
checked on Jul 1, 2024
WEB OF SCIENCETM
Citations
15
checked on Jul 2, 2024
Page view(s)
75
checked on Jul 16, 2024
Download(s)
19
checked on Jul 16, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License